<VariationArchive RecordType="classified" VariationID="2637651" VariationName="NC_000023.10:g.(?_13752866)_(13757152_13762533)del" VariationType="Deletion" Accession="VCV002637651" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-25" DateCreated="2023-11-20" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2805129" VariationID="2637651">
      <GeneList>
        <Gene Symbol="OFD1" FullName="OFD1 centriole and centriolar satellite protein" GeneID="8481" HGNC_ID="HGNC:2567" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="13714505" stop="13773738" display_start="13714505" display_stop="13773738" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="13752831" stop="13787479" display_start="13752831" display_stop="13787479" Strand="+" />
          </Location>
          <OMIM>300170</OMIM>
          <Haploinsufficiency last_evaluated="2021-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OFD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OFD1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_13752866)_(13757152_13762533)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="13752866" innerStop="13757152" outerStop="13762533" display_start="13752866" display_stop="13762533" variantLength="9668" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_13752866)_(13757152_13762533)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_13752866)_(13757152_13762533)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_13752866)_(13757152_13762533)del AND Orofaciodigital syndrome I" Accession="RCV003404949" Version="1">
        <ClassifiedConditionList TraitSetID="3148">
          <ClassifiedCondition DB="MedGen" ID="C1510460">Orofaciodigital syndrome I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-11-20" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3148" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3323" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OFDS I</ElementValue>
                <XRef Type="MIM" ID="311200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Orofaciodigital syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OFD syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oral-facial-digital syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Papillon-League-Psaume syndrome (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Orofaciodigital syndrome I</ElementValue>
                <XRef ID="MONDO:0010702" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OFDS 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Papillon-Leage and Psaume Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oral-Facial-Digital Syndrome Type I</ElementValue>
                <XRef ID="NBK1188" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OFD1</ElementValue>
                <XRef Type="MIM" ID="311200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Oral-facial-digital syndrome type I (OFD1) is usually male lethal during gestation and predominantly affects females. OFD1 is characterized by the following features: Oral (lobulated tongue, tongue nodules, cleft of the hard or soft palate, accessory gingival frenulae, hypodontia, and other dental abnormalities). Facial (widely spaced eyes or telecanthus, hypoplasia of the alae nasi, median cleft or pseudocleft upper lip, micrognathia). Digital (brachydactyly, syndactyly, clinodactyly of the fifth finger; duplicated hallux [great toe]). Kidney (polycystic kidney disease). Brain (e.g., intracerebral cysts, agenesis of the corpus callosum, cerebellar agenesis with or without Dandy-Walker malformation). Intellectual disability (in ~50% of individuals).</Attribute>
                <XRef ID="NBK1188" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4121" />
                <XRef ID="4121" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301367</ID>
                <ID Source="BookShelf">NBK1188</ID>
              </Citation>
              <XRef ID="2750" DB="Orphanet" />
              <XRef ID="C1510460" DB="MedGen" />
              <XRef ID="MONDO:0010702" DB="MONDO" />
              <XRef Type="MIM" ID="311200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7702367" SubmissionDate="2023-11-14" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_13752866)_(13757152_13762533)del|MedGen:C1510460" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004122690" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: The variant identified by MLPA or other technology involves the deletion of exons 1-5 in the OFD1 gene, where exon 1 contains the translation initiation codon. The exact breakpoint at the 5' end of this variant is unknown and therefore this deletion might extend upstream of the assayed region of the gene. A presumed nomenclature of c.(?_-325)_(412+1_413-1)del has been designated for the purposes of this classification. Although exact breakpoints of this deletion are not known, it is expected to result in an absent or shortened protein product, a known mechanism of disease. The variant was absent in 15814 control chromosomes (gnomAD, structural variants dataset). To our knowledge, no occurrence of c.(?_-325)_(412+1_413-1)del in individuals affected with Orofaciodigital Syndrome I and no experimental evidence demonstrating its impact on protein function have been reported. However, several variants located in the deleted region have been observed in individuals affected with Orofaciodigital Syndrome I (HGMD database), including at least one that has been classified as pathogenic in ClinVar, suggesting the deletion of exons 1-5 would be deterimental to protein function. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OFD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_13752866)_(13757152_13762533)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1510460" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13972740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7702367" TraitType="Disease" MappingType="XRef" MappingValue="C1510460" MappingRef="MedGen">
        <MedGen CUI="C1510460" Name="Orofaciodigital syndrome I" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

